Acorah Software Products - Accounts Production 19.3.600 false true 30 November 2024 1 December 2023 false true No description of principal activity 1 December 2024 30 November 2025 30 November 2025 09315791 Mr Akindayo Adegbesan Mr Nickesh Gadhvi Mr Samuel Osunsanya iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09315791 2024-11-30 09315791 2025-11-30 09315791 2024-12-01 2025-11-30 09315791 frs-core:Non-currentFinancialInstruments 2025-11-30 09315791 frs-bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 09315791 frs-bus:FilletedAccounts 2024-12-01 2025-11-30 09315791 frs-bus:Micro-entities 2024-12-01 2025-11-30 09315791 frs-bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 09315791 frs-bus:Director1 2024-12-01 2025-11-30 09315791 frs-bus:Director2 2024-12-01 2025-11-30 09315791 frs-bus:Director3 2024-12-01 2025-11-30 09315791 2023-11-30 09315791 2024-11-30 09315791 2023-12-01 2024-11-30 09315791 frs-core:Non-currentFinancialInstruments 2024-11-30
Registered number: 09315791
Nsa Pharma Limited
Unaudited Financial Statements
For The Year Ended 30 November 2025
Nsa Pharma Limited
Balance Sheet
As At 30 November 2025
Balance Sheet
Registered number: 09315791

| 2025 | 2024
--- | --- | ---
|  | £ | £
Fixed assets |  | 2,745 | 2,745
Current assets |  | 1,216 | 7,736
NET CURRENT ASSETS |  | 1,216 | 7,736
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 3,961 | 10,481
Creditors: Amounts Falling Due After More Than One Year |  | (37,662 ) | (41,812 )
Accruals and deferred income |  | (1,200 ) | (1,200 )
NET LIABILITIES |  | (34,901 ) | (32,531 )
CAPITAL AND RESERVES |  | (34,901 ) | (32,531 )

## Notes

1. General Information
Nsa Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 09315791 . The registered office is 3 Brooks Parade, Green Lane, Ilford, Essex, IG3 9RT.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Mr Samuel Osunsanya Director
18/08/2026